
To study the effect of zzso zzso zzso used in comprehensive treatment on zzso stage zzso 

One hundred and fifty patients with zzso cancer were equally zzso into the comprehensive treatment group zzso zzso and the control group zzso B), both groups were treated systematically according to the zzso 2005 cancer practice zzso but 20 zzso of zzso was given additionally to group A every zzso 

After treatment, the level of plasma zzso and zzso ratio were significantly lower in group B than those in group A zzso zzso zzso the response rate zzso was zzso zzso and zzso zzso in group B and A respectively, showing insignificant difference zzso and the clinical benefit rate zzso zzso zzso in group A, lower than that in group B zzso zzso zzso zzso the quality of life zzso in group A was superior to that in group B zzso and the zzso of main adverse reaction to zzso agents was significantly lower in group A as compared to that in group B zzso 

zzso could regulate the function of zzso subsets, raise the zzso and zzso and reduce adverse reaction of chemotherapy in patients with zzso stage zzso 

